126 related articles for article (PubMed ID: 17544413)
41. Analysis of proteins dominantly expressed in hepatic stellate cells of activated phenotype.
Kawada N
Methods Mol Med; 2005; 117():371-9. PubMed ID: 16118463
[TBL] [Abstract][Full Text] [Related]
42. Methylation of cyclin-dependent kinase inhibitors, XAF1, JUNB, CDH13 and soluble Wnt inhibitors in essential thrombocythaemia.
Chim CS; Fung TK; Liang R
J Clin Pathol; 2010 Jun; 63(6):518-21. PubMed ID: 20364027
[TBL] [Abstract][Full Text] [Related]
43. The gene encoding R-spondin 4 (RSPO4), a secreted protein implicated in Wnt signaling, is mutated in inherited anonychia.
Blaydon DC; Ishii Y; O'Toole EA; Unsworth HC; Teh MT; Rüschendorf F; Sinclair C; Hopsu-Havu VK; Tidman N; Moss C; Watson R; de Berker D; Wajid M; Christiano AM; Kelsell DP
Nat Genet; 2006 Nov; 38(11):1245-7. PubMed ID: 17041604
[TBL] [Abstract][Full Text] [Related]
44. Age-related increase in Wnt inhibitor causes a senescence-like phenotype in human cardiac stem cells.
Nakamura T; Hosoyama T; Murakami J; Samura M; Ueno K; Kurazumi H; Suzuki R; Mikamo A; Hamano K
Biochem Biophys Res Commun; 2017 Jun; 487(3):653-659. PubMed ID: 28435069
[TBL] [Abstract][Full Text] [Related]
45. The metabolic syndrome: how it may influence hepatic stellate cell activation and hepatic fibrosis.
Lanthier N; Horsmans Y; Leclercq IA
Curr Opin Clin Nutr Metab Care; 2009 Jul; 12(4):404-11. PubMed ID: 19474722
[TBL] [Abstract][Full Text] [Related]
46. Generation of a monoclonal human single chain antibody fragment to hepatic stellate cells--a potential mechanism for targeting liver anti-fibrotic therapeutics.
Elrick LJ; Leel V; Blaylock MG; Duncan L; Drever MR; Strachan G; Charlton KA; Koruth M; Porter AJ; Wright MC
J Hepatol; 2005 Jun; 42(6):888-96. PubMed ID: 15885360
[TBL] [Abstract][Full Text] [Related]
47. Monounsaturated fatty acid modification of Wnt protein: its role in Wnt secretion.
Takada R; Satomi Y; Kurata T; Ueno N; Norioka S; Kondoh H; Takao T; Takada S
Dev Cell; 2006 Dec; 11(6):791-801. PubMed ID: 17141155
[TBL] [Abstract][Full Text] [Related]
48. Eating bone or adding it: the Wnt pathway decides.
Goldring SR; Goldring MB
Nat Med; 2007 Feb; 13(2):133-4. PubMed ID: 17290270
[No Abstract] [Full Text] [Related]
49. Focus on molecules: SFRP1.
Mao W; Wordinger RJ; Clark AF
Exp Eye Res; 2010 Nov; 91(5):552-3. PubMed ID: 20478307
[No Abstract] [Full Text] [Related]
50. SFRP1 decreases WNT-Mediated M2 macrophage marker expression in breast tissue.
Gregory KJ; Mason H; Casaubon J; Schneider SS
Cancer Immunol Immunother; 2024 Mar; 73(5):86. PubMed ID: 38554160
[TBL] [Abstract][Full Text] [Related]
51. Morphogen-related therapeutic targets for liver fibrosis.
Fung E; Tsukamoto H
Clin Res Hepatol Gastroenterol; 2015 Sep; 39 Suppl 1(0 1):S69-74. PubMed ID: 26206577
[TBL] [Abstract][Full Text] [Related]
52. Emerging role and therapeutic implication of Wnt signaling pathways in liver fibrosis.
Wang JN; Li L; Li LY; Yan Q; Li J; Xu T
Gene; 2018 Oct; 674():57-69. PubMed ID: 29944952
[TBL] [Abstract][Full Text] [Related]
53. [Progress of research on Chinese material medica serum and hepatic stellate cells].
Yang C; Li CP
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2006 Aug; 26(8):764-7. PubMed ID: 16970107
[TBL] [Abstract][Full Text] [Related]
54. [Targeted glycyrrhetinic acid to receptors of hepatic stellate cells for the treatment of rat liver fibrosis: a pilot study].
Zhang QS; Yuan RH; Zhang J; Tian GY
Zhonghua Gan Zang Bing Za Zhi; 2004 Aug; 12(8):512. PubMed ID: 15329226
[No Abstract] [Full Text] [Related]
55. [Wnt signaling and cancer].
Hamada F
Kaibogaku Zasshi; 2009 Dec; 84(4):111-2. PubMed ID: 20030182
[No Abstract] [Full Text] [Related]
56. Secreted frizzled-related protein 1 (SFRP1) protects fibroblasts from ceramide-induced apoptosis.
Han X; Amar S
J Biol Chem; 2004 Jan; 279(4):2832-40. PubMed ID: 14581477
[TBL] [Abstract][Full Text] [Related]
57. [Effects of tetrandrine on transmembrane signaling in rat hepatic stellate cells].
Chen YW; Li DG; Wu JX; Chen YW; Lu HM
Zhonghua Gan Zang Bing Za Zhi; 2005 Aug; 13(8):609-10. PubMed ID: 16092991
[No Abstract] [Full Text] [Related]
58. Stellate cells: a moving target in hepatic fibrogenesis.
Friedman SL
Hepatology; 2004 Nov; 40(5):1041-3. PubMed ID: 15486918
[No Abstract] [Full Text] [Related]
59. Review on chemogenomics approach: interpreting antagonist activity of secreted frizzled-related protein 1 in glaucoma disease with in-silico docking.
Dave K; Panchal H
Curr Top Med Chem; 2012; 12(16):1834-42. PubMed ID: 23030617
[TBL] [Abstract][Full Text] [Related]
60. Human hepatic stellate cells are resistant to apoptosis: implications for human fibrogenic liver disease.
Kawada N
Gut; 2006 Aug; 55(8):1073-4. PubMed ID: 16849344
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
